BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis
Nienke M.G. Rorije(Pediatric Nephrology of Alabama), Francisco M. Marty(Brigham and Women's Hospital), Margaret M. Shea(Brigham and Women's Hospital), Vincent T. Ho(Dana-Farber Cancer Institute), Sarah P. Hammond(Dana-Farber Cancer Institute), Joseph H. Antin(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Lindsey R. Baden(Brigham and Women's Hospital), Gowri Satyanarayana
Cited by 68
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k